Homocysteine stimulates nuclear factor κB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells:: a possible role for protein kinase C

被引:113
作者
Wang, GP [1 ]
Siow, YL [1 ]
O, K [1 ]
机构
[1] Univ Hong Kong, Fac Med, Inst Cardiovasc Sci & Med, Dept Pharmacol, Pokfulam, Hong Kong, Peoples R China
关键词
atherosclerosis; calcium; I kappa B alpha; oxidative stress; phosphorylation;
D O I
10.1042/0264-6021:3520817
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine that stimulates the migration of monocytes into the intima of arterial walls. Although many factors that induce MCP-1 expression have been identified, the effect of homocysteine on the expression of MCP-1 in atherogenesis and the underlying mechanisms are not entirely clear. The objective of the present study was to investigate the role of homocysteine in MCP-1 expression in human aorta vascular smooth-muscle cells (VSMCs). After VSMCs were incubated with homocysteine for various time periods, a nuclease protection assay and ELISA were performed. Homocysteine (0.05-0.2 mM) significantly increased the expression of MCP-1 mRNA (up to 2.7-fold) and protein (up to 3.3-fold) in these cells. The increase in MCP-1 expression was associated with the activation of protein kinase C (PKC) as well as nuclear factor kappaB (NF-kappaB). Further investigation demonstrated that the activation of NF-kappaB was the result of a PKC-mediated reduction in the expression of inhibitory protein (I kappaB alpha) mRNA and protein in homocysteine-treated cells. Oxidative stress might also be involved in the activation of NF-kappaB by homocysteine in VSMCs. In conclusion, the present study has clearly demonstrated that the activation of PKC as well as superoxide production followed by activation of NF-kappaB is responsible for homocysteine-induced MCP-1 expression in VSMCs. These results suggest that homocysteine-stimulated MCP-1 expression via NF-kappaB activation may play an important role in atherogenesis.
引用
收藏
页码:817 / 825
页数:9
相关论文
共 52 条
[1]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[2]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[3]   Role of nuclear factor-kappa B in atherogenesis [J].
Brand, K ;
Page, S ;
Walli, AK ;
Neumeier, D ;
Baeuerle, PA .
EXPERIMENTAL PHYSIOLOGY, 1997, 82 (02) :297-304
[4]  
BROWN Z, 1994, AM J PATHOL, V145, P913
[5]   Site-specific phosphorylation of I kappa B alpha by a novel ubiquitination-dependent protein kinase activity [J].
Chen, ZJ ;
Parent, L ;
Maniatis, T .
CELL, 1996, 84 (06) :853-862
[6]   HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE [J].
CLARKE, R ;
DALY, L ;
ROBINSON, K ;
NAUGHTEN, E ;
CAHALANE, S ;
FOWLER, B ;
GRAHAM, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) :1149-1155
[7]   Very low-density lipoprotein activates nuclear factor-κB in endothelial cells [J].
Dichtl, W ;
Nilsson, L ;
Goncalves, I ;
Ares, MPS ;
Banfi, C ;
Calara, F ;
Hamsten, A ;
Eriksson, P ;
Nilsson, J .
CIRCULATION RESEARCH, 1999, 84 (09) :1085-1094
[8]   Homocyst(e)ine: An important risk factor for atherosclerotic vascular disease [J].
Duell, PB ;
Malinow, MR .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (01) :28-34
[9]   Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-κB in primary human vascular smooth muscle cells [J].
Eickelberg, O ;
Roth, M ;
Mussmann, R ;
Rüdiger, JJ ;
Tamm, M ;
Perruchoud, AP ;
Block, LH .
CIRCULATION, 1999, 99 (17) :2276-2282
[10]   Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells [J].
Erl, W ;
Hansson, GK ;
de Martin, R ;
Draude, G ;
Weber, KSC ;
Weber, C .
CIRCULATION RESEARCH, 1999, 84 (06) :668-677